HEPATOCEREBRAL DEGENERATION: A CLINICAL CASE OF A RARE DISEASE
Vol. 5 No. 10 (2025): Eurasian Journal of Medical and Natural Sciences 70-75
Abstract
Hepatocerebral degeneration, also known as acquired hepatocerebral degeneration (AHD), is a rare neurological complication of chronic liver disease. It results from the accumulation of neurotoxic substances such as manganese and ammonia in the central nervous system, primarily affecting the basal ganglia. The condition manifests as extrapyramidal symptoms, tremor, rigidity, cognitive impairment, and psychiatric disturbances. This article presents a clinical case of a 52-year-old male with chronic liver cirrhosis who developed progressive neurological symptoms consistent with hepatocerebral degeneration. Diagnostic imaging, laboratory results, and therapeutic management are described. The report highlights the importance of early recognition and multidisciplinary treatment to prevent irreversible brain damage.
Keywords:
References
Butterworth R.F. Hepatic Encephalopathy in Cirrhosis: Pathology and Pathophysiology. Drugs. 2019; 79 (s1): 17–21. doi:10.1007/s40265-018-1017-0.
Victor M., Adams R.D., Cole M. The acquired (non-Wilsonian) type of chronic hepatocerebral degeneration. Medicine (Baltimore). 1965; 44 (5): 345–396. doi:10.1097/00005792-196509000-00001
Шульпекова Ю.О., Павлов Ч.С., Дамулин И.В. Приобретенная невильсоновная гепатоцеребральная дегенерация как особая форма персистирующей печеночной энцефалопатии. Неврологический журнал. 2017; 22 (1): 10–18. doi:10.18821/1560-9545- 2017-22-1-10-18. [Shul'pekova Ju.O., Pavlov Ch.S., Damulin I.V. Priobretennaja nevil'sonovnaja gepatocerebral'naja degeneracija kak osobaja forma persistirujushhej pechenochnoj jencefalopatii. The Neurological Journale. 2017; 22(1): 10–18 (in Russian)] 53Трудный пациент №5, ТОМ 19, 2021 РЕДКИЕ ЗАБОЛЕВАНИЯ
Полещук В.В., Яковенко Е.В., Федотова Е.Ю., Иллариошкин С.Н. Приобретенная невильсоновская гепатоцеребральная дегенерация. Нервные болезни. 2019; 1: 34– 39. doi:10.24411/2071-5315-2018-12077. [Poleshhuk V.V., Jakovenko E.V., Fedotova E.Ju., Illarioshkin S.N. Priobretennaja nevil'- sonovskaja gepatocerebral'naja degeneracija. Nervnye bolezni. 2019; 1: 34-39 [in Russian]]
Cersosimo M.G., Koller W.C. The diagnosis of manganese-induced parkinsonism. Neurotoxicology. 2006; 27 (3): 340–346. doi:10.1016/j.neuro.2005.10.006.
Bouabid S., Tinakoua A., Lakhdar-Ghazal N., Benazzouz A. Manganese neurotoxicity: behavioral disorders associated with dysfunctions in the basal ganglia and neurochemical transmission. J Neurochem. 2016; 136 (4): 677–691. doi:10.1111/jnc.13442.
Layrargues G.P., Rose C., Spahr L., Zayed J., Normandin L., Butterworth R.F. Role of manganese in the pathogenesis of portal-systemic encephalopathy. Metab Brain Dis. 1998; 13 (4): 311–317. doi:10.1023/a:1020636809063.
Bosimov M., Boboniyazov K, CLINICAL AND MOLECULAR GENETIC DIAGNOSTICS OF WILSON-KONOVALOV DISEASE. EURASIAN JOURNAL OF MEDICAL AND NATURAL SCIENCES Innovative Academy Research Support Center, 2025; 5 156-159
Butterworth, R. F. (2019). Acquired hepatocerebral degeneration: Mechanisms and management. Metabolic Brain Disease, 34(6), 1781–1789. https://doi.org/10.1007/s11011-019-00479-1
Mínguez, B., Córdoba, J., & Alonso, J. (2018). Acquired hepatocerebral degeneration in cirrhotic patients: Clinical and MRI findings. Journal of Hepatology, 68(5), 1020–1030. https://doi.org/10.1016/j.jhep.2018.01.010
McKinney, A. M., Kieffer, S. A., Paylor, R. T., SantaCruz, K. S., & Kendi, A. T. (2016). MR imaging of acquired hepatocerebral degeneration: Correlation with clinical findings and manganese levels. American Journal of Neuroradiology, 37(2), 280–286. https://doi.org/10.3174/ajnr.A4498
Hauser, R. A., & Zesiewicz, T. A. (2015). Manganese neurotoxicity: A review of clinical and imaging features. Neurotoxicology, 49, 132–141. https://doi.org/10.1016/j.neuro.2015.05.007
Readership
Downloads
Published
Issue
Section
How to Cite
